Sonographic Evaluation Of Uterine Fibroids At Different Locations In Patient With Irregular Menstrul Cycle
1 other identifier
observational
97
1 country
1
Brief Summary
Uterine fibroids are a major cause of illness in women of a reproductive age. There are many factors involved in the growth and reduction of these common tumors. The most likely cause of fibroids is their effect on a woman's menstrual cycle. For accurate diagnosis numerous diagnostic markers on ultrasound are present which increases the efficacy of ultrasound to diagnose uterine fibroids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2024
CompletedFirst Submitted
Initial submission to the registry
December 18, 2024
CompletedFirst Posted
Study publicly available on registry
January 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedJanuary 10, 2025
January 1, 2025
6 months
December 18, 2024
January 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
two-dimensional ultrasound scan (GE Loginq P7 convex probe.3.5-5MHz)
On ultrasound using (GE Loginq P7 convex probe.3.5-5MHz), a uterine fibroid is classically characterized as a solid, round, well-defined, hypoechoic, heterogeneous lesion within the myometrium, often showing acoustic shadowing at the edge of the lesion
12 Months
Interventions
To evaluate the different location of uterine fibroids in patient with disturbed menstrual cycle on ultrasound
Eligibility Criteria
Aim is to check Irregular Menstrul Cycle with Sonographic Evaluation Of Uterine Fibroids
You may qualify if:
- Patient with Pelvic pain
- Patient with Abdominal pain
- Patient with heavy bleeding
- Patient with Dysmenorrhea
- Polymenorrhea
You may not qualify if:
- Patient with H/O Cystectomy
- Patient with H/O cyst
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
THQ hospital Pattoki/ Siddique medical center Pattoki
Pattoki, Punjab Province, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 18, 2024
First Posted
January 10, 2025
Study Start
February 25, 2024
Primary Completion
August 8, 2024
Study Completion
March 1, 2025
Last Updated
January 10, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share